ESRRA and metabolic dysfunction-associated steatotic liver disease: Although systemic ablation of ERRα protects mice from HFD-induced NAFLD, the presence of ERRα promotes the reversal of fasting-induced NAFLD by stimulating hepatic mitochondrial oxidative activity and halting WAT lipolysis during refeeding (88).